Peripheral B lymphocyte β1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy

被引:69
作者
Qin, W
Zhou, Q
Yang, LC
Li, Z
Su, BH
Luo, H
Fan, JM
机构
[1] Sichuan Univ, W China Hosp, Dept Internal Med, Div Nephrol, Chengdu 610041, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, Div Gene Engineered Mouse, State Key Lab Biotherapy, Chengdu 610064, Peoples R China
关键词
beta 1,3-galactosyltransferase; C1GALT1; Cosmc; immunoglobulin A glycosylation; immunoglobulin A nephropathy; real-time reverse transcriptase polymerase chain reaction; vicia villosa lectin;
D O I
10.1111/j.1365-2796.2005.01558.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose. Aberrant O-glycosylation of serum IgA(1) is presumed to be one of the main pathogenesis of immunoglobulin A nephropathy (IgAN). beta 1,3-galactosyltransferase (beta 1,3GT), whose activity requires coexistence of a specific chaperone, is the main enzyme which participate in the glycosylation process. The current study was carried out to elucidate the expression level of beta 1,3GT (C1GALT1) and its chaperone (Cosmc) in IgAN, and their relationships with clinical features as well as IgA glycosylation level. Design, setting and subjects. Forty-one patients with IgAN, 21 patients with non-IgAN glomerulonephritis and 26 normal controls were included in the present study. Peripheral B lymphocytes were isolated, and then expression level of C1GALT1 and Cosmc were quantitatively measured by real-time reverse transcriptase polymerase chain reaction (RT-PCR). Serum IgA level and glycosylation level were determined by enzyme-linked immunosorbent assay (ELISA) and VV lectin-binding method. Correlation analysis was performed between C1GALT1/Cosmc expression levels and clinical manifestations (severe proteinuria, renal dysfunction, gross haematuria). Results. B-lymphocyte Cosmc gene expression level was significantly lower in IgAN patients than that of normal control and non-IgAN patients (P < 0.05), whilst no apparent disparity was observed in C1GALT1 expression level. Cosmc expression showed a negative correlation with IgA O-glycosylation level indicated by VV lectin-binding assay. Statistical analysis also indicated that the level of Cosmc expression was negatively correlated with severe proteinuria (P < 0.05) instead of gross haematuria (P > 0.05). Conclusion. These data suggested that the aberrant IgA O-glycosylation in IgAN was resulted from a downregulation of beta 1,3GT chaperone (Cosmc) expression in B lymphocyte, which is closely associated with clinical characteristics of the disease. This downregulation might be one of the fundamental pathogenic abnormalities in IgAN.
引用
收藏
页码:467 / 477
页数:11
相关论文
共 28 条
[1]   2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[2]   Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy [J].
Allen, AC ;
Topham, PS ;
Harper, SJ ;
Feehally, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (04) :701-706
[3]   Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients [J].
Allen, AC ;
Bailey, EM ;
Brenchley, PEC ;
Buck, KS ;
Barratt, J ;
Feehally, J .
KIDNEY INTERNATIONAL, 2001, 60 (03) :969-973
[4]   Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis [J].
Allen, AC ;
Willis, FR ;
Beattie, TJ ;
Feehally, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (04) :930-934
[5]   Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells [J].
Amore, A ;
Conti, G ;
Cirina, P ;
Peruzzi, L ;
Alpa, M ;
Bussolino, F ;
Coppo, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (06) :1242-1252
[6]  
Amore A, 2001, J AM SOC NEPHROL, V12, P1862, DOI 10.1681/ASN.V1291862
[7]  
Basset C, 1999, SCAND J IMMUNOL, V50, P572
[8]  
Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395
[9]  
GOMEZGUERRERO C, 1993, CONTRIB NEPHROL, V104, P127
[10]   Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases [J].
Haas, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (06) :829-842